v1
A prospective, multicenter, open-label trial of zoledronic acid in patients with hormone refractory prostate cancer.
- NobleID
- NI5P20W50R41S47
- Persistent link
- https://nobleid.org/ark:/48914/w1/20260515/B55DFE09
Type:Journal Article
0 views
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims